Cargando…

Vector Saliva in Vaccines for Visceral Leishmaniasis: A Brief Encounter of High Consequence?

Visceral leishmaniasis (VL) is a vector-borne disease transmitted by phlebotomine sand flies and remains the most serious form of the disease with no available human vaccine. Repeatedly, studies have demonstrated the immunogenicity and protective efficacy of a number of sand fly salivary proteins ag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamhawi, Shaden, Aslan, Hamide, Valenzuela, Jesus G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126209/ https://www.ncbi.nlm.nih.gov/pubmed/25152872 http://dx.doi.org/10.3389/fpubh.2014.00099

Ejemplares similares

Comparative salivary gland transcriptomics of sandfly vectors of visceral leishmaniasis
por: Anderson, Jennifer M, et al.
Publicado: (2006)

Biomarkers for Zoonotic Visceral Leishmaniasis in Latin America
por: Brodskyn, Claudia I., et al.
Publicado: (2018)

Development of a Natural Model of Cutaneous Leishmaniasis: Powerful Effects of Vector Saliva and Saliva Preexposure on the Long-Term Outcome of Leishmania major Infection in the Mouse Ear Dermis
por: Belkaid, Yasmine, et al.
Publicado: (1998)

The human immune response to saliva of Phlebotomus alexandri, the vector of visceral leishmaniasis in Iraq, and its relationship to sand fly exposure and infection
por: Lakhal-Naouar, Ines, et al.
Publicado: (2021)

A defined subunit vaccine that protects against vector-borne visceral leishmaniasis
por: Duthie, Malcolm S., et al.
Publicado: (2017)

Sand Fly Salivary Proteins Induce Strong Cellular Immunity in a Natural Reservoir of Visceral Leishmaniasis with Adverse Consequences for Leishmania
por: Collin, Nicolas, et al.
Publicado: (2009)

Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis
por: Cecílio, Pedro, et al.
Publicado: (2017)

Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis
por: Karmakar, Subir, et al.
Publicado: (2021)

The yin and yang of leishmaniasis control
por: Kamhawi, Shaden
Publicado: (2017)

Implicating bites from a leishmaniasis sand fly vector in the loss of tolerance in pemphigus
por: Marzouki, Soumaya, et al.
Publicado: (2020)

Immunity to vector saliva is compromised by short sand fly seasons in endemic regions with temperate climates
por: Oliveira, Fabiano, et al.
Publicado: (2020)

Building Research and Development Capacity for Neglected Tropical Diseases Impacting Leishmaniasis in the Middle East and North Africa: A Case Study
por: Rafati, Sima, et al.
Publicado: (2015)

Using Recombinant Proteins from Lutzomyia longipalpis Saliva to Estimate Human Vector Exposure in Visceral Leishmaniasis Endemic Areas
por: Souza, Ana Paula, et al.
Publicado: (2010)

Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis
por: Karmakar, Subir, et al.
Publicado: (2022)

New Insights Into the Transmissibility of Leishmania infantum From Dogs to Sand Flies: Experimental Vector-Transmission Reveals Persistent Parasite Depots at Bite Sites
por: Aslan, Hamide, et al.
Publicado: (2016)

Circulating Biomarkers of Immune Activation, Oxidative Stress and Inflammation Characterize Severe Canine Visceral Leishmaniasis
por: Solcà, Manuela S., et al.
Publicado: (2016)

Impaired development of a miltefosine-resistant Leishmania infantum strain in the sand fly vectors Phlebotomus perniciosus and Lutzomyia longipalpis
por: Van Bockstal, Lieselotte, et al.
Publicado: (2019)

Leishmania donovani visceral leishmaniasis diagnosed by metagenomics next-generation sequencing in an infant with acute lymphoblastic leukemia: a case report
por: Chang, Li, et al.
Publicado: (2023)

Seroprevalence of visceral leishmaniasis and its associated factors among asymptomatic pastoral community of Dire District, Borena zone, Oromia Region, Ethiopia
por: Ketema, Haile, et al.
Publicado: (2022)

Validation of Recombinant Salivary Protein PpSP32 as a Suitable Marker of Human Exposure to Phlebotomus papatasi, the Vector of Leishmania major in Tunisia
por: Marzouki, Soumaya, et al.
Publicado: (2015)

Epidemiologic Aspects of an Emerging Focus of Visceral Leishmaniasis in Tbilisi, Georgia
por: Giorgobiani, Ekaterina, et al.
Publicado: (2011)

Immune response dynamics and Lutzomyia longipalpis exposure characterize a biosignature of visceral leishmaniasis susceptibility in a canine cohort
por: Solcà, Manuela da Silva, et al.
Publicado: (2021)

Quantification of the natural history of visceral leishmaniasis and consequences for control
por: Chapman, Lloyd A C, et al.
Publicado: (2015)

Editorial: Vector-borne diseases and consequences on human health: a multidisciplinary approach
por: Tabbabi, Ahmed, et al.
Publicado: (2023)

Coinfection With Trypanosoma brucei Confers Protection Against Cutaneous Leishmaniasis
por: Pereira, Lais, et al.
Publicado: (2018)

Measurement of Recent Exposure to Phlebotomus argentipes, the Vector of Indian Visceral Leishmaniasis, by Using Human Antibody Responses to Sand Fly Saliva
por: Clements, Meredith F., et al.
Publicado: (2010)

Understanding non-vaccinating parents’ views to inform and improve clinical encounters: a qualitative study in an Australian community
por: Helps, Catherine, et al.
Publicado: (2019)

Delayed-Type Hypersensitivity to Sand Fly Saliva in Humans from a Leishmaniasis-Endemic Area of Mali Is T(H)1-Mediated and Persists to Midlife
por: Oliveira, Fabiano, et al.
Publicado: (2013)

Toward a Defined Anti-Leishmania Vaccine Targeting Vector Antigens: Characterization of a Protective Salivary Protein
por: Valenzuela, Jesus G., et al.
Publicado: (2001)

Hematological consequences of malaria in mice previously treated for visceral leishmaniasis
por: Rani, Gulab Fatima, et al.
Publicado: (2021)

Distinct gene expression patterns in vector-residing Leishmania infantum identify parasite stage-enriched markers
por: Coutinho-Abreu, Iliano V., et al.
Publicado: (2020)

Development of Vaccines against Visceral Leishmaniasis
por: Evans, Krystal J., et al.
Publicado: (2012)

Experimental Infection of Dogs with Leishmania and Saliva as a Model to Study Canine Visceral Leishmaniasis
por: Costa, Dirceu Joaquim, et al.
Publicado: (2013)

Brief encounter
por: Leslie, Mitch
Publicado: (2006)

Evasion of tumours from the control of the immune system: consequences of brief encounters
por: Al-Tameemi, Mohannad, et al.
Publicado: (2012)

Challenges during the realization of an international research project on leishmaniasis in Colombia
por: Suschinel, Raluca, et al.
Publicado: (2023)

Saliva Liquid Biopsy for Point-of-Care Applications
por: Aro, Katri, et al.
Publicado: (2017)

Vector Transmission of Leishmania Abrogates Vaccine-Induced Protective Immunity
por: Peters, Nathan C., et al.
Publicado: (2009)

Aircraft and Risk of Importing a New Vector of Visceral Leishmaniasis
por: Costa, Carlos H.N., et al.
Publicado: (2011)

Human visceral leishmaniasis and relationship with vector and canine control measures
por: Costa, Danielle Nunes Carneiro Castro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ekst9s30lc07a7qkgal5836e7e